Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets

Blood

Volumn 131, Issue 7, 2018, Pages 787-796

  Quach, M Edward ^a   Dragovich, Matthew A ^b   Chen, Wenchun ^a   Syed, Anum K ^a   Cao, Wenpeng ^b   Liang, Xin ^a   Deng, Wei ^a   De Meyer, Simon F ^c   Zhu, Guangheng ^d   Peng, Jun ^e   Ni, Heyu ^d   Bennett, Carolyn M ^a   Hou, Ming ^e   Ware, Jerry ^f   Deckmyn, Hans ^c   Zhang, X Frank ^b   Li, Renhao ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Lehigh University   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e SHANDONG UNIVERSITY   (China)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; GLYCOPROTEIN IB; IMMUNOGLOBULIN; LIGAND BINDING DOMAIN ANTIBODY 6B4; LIGAND BINDING DOMAIN ANTIBODY AK2; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; IMMUNOGLOBULIN FC FRAGMENT; THROMBIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CROSS LINKING; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LIGAND BINDING; MECHANORECEPTOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN UNFOLDING; SIGNAL TRANSDUCTION; THROMBOCYTE; TRANSGENIC MOUSE; ANIMAL; BLOOD; DRUG EFFECT; IMMUNOLOGY; MECHANOTRANSDUCTION; METABOLISM; PHYSIOLOGY; SHEAR STRENGTH;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD PLATELETS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULINS, INTRAVENOUS; MECHANOTRANSDUCTION, CELLULAR; MICE; MICE, TRANSGENIC; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SHEAR STRENGTH; SIGNAL TRANSDUCTION;

EID: 85042159841     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2017-05-784975     Document Type: Article

References (53)

1. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386-2393.
2. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113(26):6511-6521.
3. Chow L, Aslam R, Speck ER, et al. A murine model of severe immune thrombocytopenia is induced by antibody- and CD81 T cell-mediated responses that are differentially sensitive to therapy. Blood. 2010;115(6): 1247-1253.
4. Li J, Callum JL, Lin Y, Zhou Y, Zhu G, Ni H. Severe platelet desialylation in a patient with glycoprotein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary hemorrhage. Haematologica. 2014;99(4):e61-e63.
5. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2): 168-186.
6. Tao L, Zeng Q, Li J, et al. Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia. J Hematol Oncol. 2017;10(1):46.
7. Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost. 2006;4(11): 2377-2383.
8. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190-4207.
9. Beardsley DS, Ertem M. Platelet autoantibodies in immune thrombocytopenic purpura. Transfus Sci. 1998;19(3):237-244.
10. Harrington WJ, Minnich V, Hollingsworth JW, Moore CV. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med. 1951;38(1):1-10.
11. Go RS, Johnston KL, Bruden KC. The association between platelet autoantibody specificity and response to intravenous immunoglobulin G in the treatment of patients with immune thrombocytopenia. Haematologica. 2007;92(2):283-284.
12. Peng J, Ma SH, Liu J, et al. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study. J Thromb Haemost. 2014;12(4): 497-504.
13. Li R, Emsley J. The organizing principle of the platelet glycoprotein Ib-IX-V complex. J Thromb Haemost. 2013;11(4):605-614.
14. Zeng Q, Zhu L, Tao L, et al. Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIba antibodies. Am J Hematol. 2012;87(2): 206-208.
15. Bergmeier W, Rackebrandt K, Schröder W, Zirngibl H, Nieswandt B. Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies. Blood. 2000;95(3): 886-893.
16. Cadroy Y, Hanson SR, Kelly AB, et al. Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates. Blood. 1994;83(11): 3218-3224.
17. Cauwenberghs N, Meiring M, Vauterin S, et al. Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates. Arterioscler Thromb Vasc Biol. 2000;20(5):1347-1353.
18. Becker BH, Miller JL. Effects of an antiplatelet glycoprotein Ib antibody on hemostatic function in the guinea pig. Blood. 1989;74(2): 690-694.
19. Nieswandt B, Bergmeier W, Rackebrandt K, Gessner JE, Zirngibl H. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Blood. 2000;96(7):2520-2527.
20. Webster ML, Sayeh E, Crow M, et al. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies. Blood. 2006;108(3):943-946.
21. Li J, van der Wal DE, Zhu G, et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun. 2015;6: 7737.
22. Yan R, Chen M, Ma N, et al. Glycoprotein Iba clustering induces macrophage-mediated platelet clearance in the liver. Thromb Haemost. 2015;113(1):107-117.
23. Hoffmeister KM, Falet H. Platelet clearance by the hepatic Ashwell-Morrell receptor: mechanisms and biological significance. Thromb Res. 2016;141(Suppl 2):S68-S72.
24. Maurer E, Tang C, Schaff M, et al. Targeting platelet GPIbb reduces platelet adhesion, GPIb signaling and thrombin generation and prevents arterial thrombosis. Arterioscler Thromb Vasc Biol. 2013;33(6):1221-1229.
25. Stolla M, Stefanini L, André P, et al. CalDAG-GEFI deficiency protects mice in a novel model of Fcg RIIA-mediated thrombosis and thrombocytopenia. Blood. 2011;118(4): 1113-1120.
26. Liang X, Syed AK, Russell SR, Ware J, Li R. Dimerization of glycoprotein Iba is not sufficient to induce platelet clearance. J Thromb Haemost. 2016;14(2):381-386.
27. Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI. von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. J Clin Invest. 1991;88(5):1568-1573.
28. Zhang W, Deng W, Zhou L, et al. Identification of a juxtamembrane mechanosensitive domain in the platelet mechanosensor glycoprotein Ib-IX complex. Blood. 2015;125(3): 562-569.
29. Deng W, Xu Y, Chen W, et al. Platelet clearance via shear-induced unfolding of a membrane mechanoreceptor. Nat Commun. 2016; 7:12863.
30. Ware J, Russell S, Ruggeri ZM. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci USA. 2000;97(6):2803-2808.
31. Liang X, Russell SR, Estelle S, et al. Specific inhibition of ectodomain shedding of glycoprotein Iba by targeting its juxtamembrane shedding cleavage site. J Thromb Haemost. 2013;11(12):2155-2162.
32. Chen W, Liang X, Syed AK, et al. Inhibiting GPIba shedding preserves post-transfusion recovery and hemostatic function of platelets after prolonged storage. Arterioscler Thromb Vasc Biol. 2016;36(9):1821-1828.
33. Shen Y, Romo GM, Dong JF, et al. Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex. Blood. 2000;95(3):903-910.
34. Cauwenberghs N, Vanhoorelbeke K, Vauterin S, et al. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha. Blood. 2001;98(3):652-660.
35. Deng W, Wang Y, Druzak SA, et al. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor. J Thromb Haemost. 2017;15(9):1867-1877.
36. Mo X, Lu N, Padilla A, López JA, Li R. The transmembrane domain of glycoprotein Ibbeta is critical to efficient expression of glycoprotein Ib-IX complex in the plasma membrane. J Biol Chem. 2006;281(32): 23050-23059.
37. Chong BH, Fawaz I, Chesterman CN, Berndt MC. Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol. 1989;73(2):235-240.
38. Fredrickson BJ, Dong JF, McIntire LV, López JA. Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood. 1998;92(10):3684-3693.
39. Tao Y, Zhang X, Liang X, Zang J, Mo X, Li R. Structural basis for the specific inhibition of glycoprotein Iba shedding by an inhibitory antibody. Sci Rep. 2016;6(1):24789.
40. Chesla SE, Selvaraj P, Zhu C. Measuring two-dimensional receptor-ligand binding kinetics by micropipette. Biophys J. 1998;75(3): 1553-1572.
41. Evans E. Probing the relation between force–lifetime–and chemistry in single molecular bonds. Annu Rev Biophys Biomol Struct. 2001; 30(1):105-128.
42. Dong JF, Moake JL, Nolasco L, et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood. 2002;100(12):4033-4039.
43. Samsel L, Dagur PK, Raghavachari N, Seamon C, Kato GJ, McCoy JP Jr. Imaging flow cytometry for morphologic and pheno-typic characterization of rare circulating endothelial cells. Cytometry B Clin Cytom. 2013;84(6):379-389.
44. Basiji DA, Ortyn WE, Liang L, Venkatachalam V, Morrissey P. Cellular image analysis and imaging by flow cytometry. Clin Lab Med. 2007;27(3):653-670, viii.
45. Suzuki H, Yamamoto N, Tanoue K, Yamazaki H. Glycoprotein Ib distribution on the surface of platelets in resting and activation states: an electron microscope study. Histochem J. 1987;19(3):125-136.
46. Shrimpton CN, Borthakur G, Larrucea S, Cruz MA, Dong JF, López JA. Localization of the adhesion receptor glycoprotein Ib-IX-V complex to lipid rafts is required for platelet adhesion and activation. J Exp Med. 2002; 196(8):1057-1066.
47. Jin W, Inoue O, Tamura N, et al. A role for glycosphingolipid-enriched microdomains in platelet glycoprotein Ib-mediated platelet activation. J Thromb Haemost. 2007;5(5):1034-1040.
48. Ozaki Y, Suzuki-Inoue K, Inoue O. Platelet receptors activated via mulitmerization: glycoprotein VI, GPIb-IX-V, and CLEC-2. J Thromb Haemost. 2013;11(Suppl 1):330-339.
49. Li S, Wang Z, Liao Y, et al. The glycoprotein Ibalpha-von Willebrand factor interaction induces platelet apoptosis. J Thromb Haemost. 2010;8(2):341-350.
50. Yin H, Stojanovic A, Hay N, Du X. The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation. Blood. 2008;111(2):658-665.
51. Yin H, Liu J, Li Z, Berndt MC, Lowell CA, Du X. Src family tyrosine kinase Lyn mediates VWF/ GPIb-IX-induced platelet activation via the cGMP signaling pathway. Blood. 2008;112(4): 1139-1146.
52. Delaney MK, Liu J, Zheng Y, Berndt MC, Du X. The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation. Arterioscler Thromb Vasc Biol. 2012;32(11):2761-2768.
53. Dudko OK, Hummer G, Szabo A. Theory, analysis, and interpretation of single-molecule force spectroscopy experiments. Proc Natl Acad Sci USA. 2008;105(41):15755-15760.